Increased spinal cholecystokinin activity after systemic resiniferatoxin: Electrophysiological and in situ hybridization studies

Pain

Volumn 84, Issue 1, 2000, Pages 21-28

  Broberger, Christian ^a   Farkas Szallasi, Tünde ^a   Szallasi, Arpad ^a   Lundberg, Jan M ^a   Hökfelt, Tomas ^a   Wiesenfeld Hallin, Zsuzsanna ^b   Xu, Xiao Jun ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Div Clin Neurophysiol   (Sweden)

Author keywords

Analgesia; Capsaicin; CCK receptors; Cholecystokinin (CCK); Dorsal root ganglion; Morphine; Opioids; Pain; Resiniferatoxin

Indexed keywords

CAPSAICIN DERIVATIVE; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; MESSENGER RNA; MORPHINE; RESINIFERATOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ELECTROPHYSIOLOGY; FLEXOR REFLEX; HOT PLATE TEST; HYPOALGESIA; IN SITU HYBRIDIZATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA ANALYSIS; SPINAL GANGLION; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

ANIMALS; CHOLECYSTOKININ; DECEREBRATE STATE; DITERPENES; GANGLIA, SPINAL; HORMONE ANTAGONISTS; INDOLES; INJECTIONS, SUBCUTANEOUS; MALE; MEGLUMINE; MORPHINE; NEURONS; NEUROTOXINS; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; REFLEX; RNA, MESSENGER; SPINAL CORD; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033991857     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00173-6     Document Type: Article

References (39)

1. Arnér L.D., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
2. Bevan S., Szolcsnyi J. Sensory neuron-specific actions of capsaicin: mechanisms and applications. Trends Pharmacol Sci. 11:1990;330-333.
3. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 389:1997;816-824.
4. Cesselin F. Opioid and anti-opioid peptides. Fund Clin Pharmacol. 9:1995;409-433.
5. Cortés R., Arvidsson U., Schalling M., Ceccatelli S., Hökfelt T. In situ hybridization studies on mRNAs for cholecystokinin, calcitonin gene-related peptide and choline acetyltransferase in the lower brain stem, spinal cord and dorsal root ganglia of rat and guinea pig with special reference to motoneurons. J Chem Neuroanat. 3:1990;467-485.
6. Dagerlind Å., Friberg K., Bean A., Hökfelt T. Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry. 98:1992;39-49.
7. Deschenes R.J., Lorenz L.J., Haun R.S., Roos B.A., Collier K.J., Dixon J.E. Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. Proc Natl Acad Sci USA. 81:1984;726-730.
8. DeVries D.J., Blumberg P.M. Thermoregulatory effects of resiniferatoxin in the mouse: comparison with capsaicin. Life Sci. 44:1989;711-715.
9. Dickenson A.H. Neurophysiology of opioid poorly responsive pain. Cancer Surv. 21:1994;5-16.
10. Farkas-Szallasi T., Lundberg J.M., Wiesenfeld-Hallin Z., Hökfelt T., Szallasi A. Increased levels of GMAP. VIP and nitric oxide synthase, and their mRNAs, in lumbar dorsal root ganglia of the rat following systemic resiniferatoxin treatment. NeuroReport. 6:1995;2230-2234.
11. Fuji K., Senba E., Fujii S., Nomura I., Wu J.Y., Ueda U., Tohyama M. Distribution, ontogeny and projections of cholecystokinin-8, vasoactive intestinal polypeptide and γ-aminobytyrate-containing neuron systems in the rat spinal cord: an immunohistochemical analysis. Neuroscience. 14:1985;881-894.
12. Ghilardi J.R., Allen C.J., Steven R.V., McVey D.C., Mantyh P.W. Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: possible site of opiate-CCK analgesic interactions. J Neurosci. 12:1992;4854-4866.
13. Hergenhahn M., Adolph W., Hecker E. Resiniferatoxin and other esters of novel polyfunctional diterpenes from Euphorbia resinifera and unispina. Tetrahedron Lett. 19:1975;1595-1598.
14. Hökfelt T., Zhang X., Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 17:1994;22-30.
15. Hökfelt T., Skirboll L., Everitt B.J., Meister B., Brownstein M., Jacobs T., Faden A., Kuga S., Goldstein M., Markstein R., Dockray G., Rehfeld J. Distribution of cholecystokinin-like immunoreactivity in the nervous system with special reference to coexistence with classical neurotransmitters and other neuropeptides. Ann N Y Acad Sci. 448:1985;255-274.
16. Hökfelt T., Zhang X., Xu Z.-Q., Ji R.-R., Shi T., Corness J., Kerekes N., Landry M., Rydh-Rinder M., Broberger C., Wiesenfeld-Hallin Z., Bartfai T., Elde R., Ju G. Transition of pain from acute to chronic: cellular and synaptic mechanism. Jensen T.S., Turner J.A., Wiesenfeld-Hallin Z. Proc. 8th World Congress on Pain, Prog. Pain Res. Manag. vol. 8. 1997;133-154 IASP Press, Seattle.
17. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev. 43:1991;144-201.
18. Hughes J., Boden P., Costall B., Domeney A., Kelly E., Horwell D.C., Hunter J.C., Pinnock R.D., Woodruff G.N. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA. 87:1990;6728-6732.
19. Lucas G.A., Alster P., Brodin E., Wiesenfeld-Hallin Z. Differential release of cholecystokinin by morphine in rat spinal cord. Neurosci Lett. 244:1998;1-4.
20. Mao J., Price D.D., Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain. 61:1995;353-364.
21. Stanfa L., Dickenson A.H., Xu X.J., Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol Sci. 15:1994;65-67.
22. Szallasi A. The vanilloid (capsaicin) receptor: receptor types and species difference. Gen Pharmacol. 25:1994;223-243.
23. Szallasi A., Blumberg P.M. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constitutent in red pepper. Neuroscience. 30:1989;515-520.
24. Szallasi A., Blumberg P.M. Resiniferatoxin and its analogs provide novel insight into the pharmacology of the vanilloid (capsaicin) receptor. Life Sci. 47:1990;1399-1408.
25. Szallasi A., Szallasi Z., Blumberg P.M. Permanent effects of neonatally administered resiniferatoxin in the rat. Brain Res. 514:1990;182-186.
26. Szallasi A., Nilsson S., Farkas-Szallasi T., Blumberg P.M., Hökfelt T., Lundberg J. Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res. 703:1995;175-183.
27. Szolcsnyi J., Nagy J., Pethó G. Effect of CP-96,345 a non-peptide substance P antagonist, capsaicin, resiniferatoxin and ruthenium red on nociception. Regul Pept. 46:1993;437-439.
28. Szolcsnyi J., Szallasi A., Sxallasi Z., Joo F., Blomberg P.M. Resiniferatoxin, and ultrapotent selective modulator of capsaicin sensitive primary afferent neurons. J Pharmacol Exp Ther. 255:1990;923-928.
29. Tominaga M., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 21:1998;531-543.
30. Verge V.M.K., Wiesenfeld-Hallin Z., Hökfelt T. Cholecystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies in rat and monkey. Eur J Neurosci. 5:1993;240-250.
31. Wank S.A., Harkins R., Jensen R.T., Shapira H., De Weerth A., Slattery T. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA. 89:1992;3125-3129.
32. Wank S.A., Pisegna J.R., De Weerth A. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA. 89:1992;8691-8695.
33. Wiesenfeld-Hallin Z., Xu X.J. The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance. Reg Peptides. 65:1996;23-28.
34. Wiesenfeld-Hallin Z., Xu X.J., Hughes J., Horwell D.C., Hökfelt T. PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. Proc Natl Acad Sci USA. 87:1990;7105-7109.
35. Winter J., Walpole C.S.J., Bevan S., James I.F. Characterization of resiniferatoxin binding sites on sensory neurons: co-regulation of resiniferatoxin binding and capsaicin sensitivity in adult dorsal root ganglia. Neuroscience. 57:1993;747-757.
36. Xu X.J., Puke M.J.C., Verge V.M.K., Wiesenfeld-Hallin Z., Hughes J., Hökfelt T. Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain. Neurosci Lett. 152:1993;132-139.
37. Xu X.J., Hökfelt T., Hughes J., Wiesenfeld-Hallin Z. The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats. NeuroReport. 5:1994;718-720.
38. Xu X.J., Farkas-Szallasi T., Lundberg J.M., Hökfelt T., Wiesenfeld-Hallin Z., Szallasi A. Effects of the capsaicin analogue resiniferatoxin on spinal nociceptive mechanisms in the rat: behavioural, electrophysiological and in situ hybridization studies. Brain Res. 752:1997;52-60.
39. Zhang X., Dagerlind Å., Elde R.P., Castel M.N., Broberger C., Wiesenfeld-Hallin Z., Hökfelt T. Marked increase in cholecystokinin B receptor messenger RNA levels in rat dorsal root ganglia after peripheral axotomy. Neuroscience. 57:1993;227-233.